Clinical laboratories and other healthcare settings use hematologic instruments to analyze blood and blood-related disorders. Hematology analyzers are highly specialized tools used to count the number of white blood cells, red blood cells, and platelets. Hematology analyzers are made up of multiple analytical modules with unique sample preparation processes. Based on the type of automation, fully automated and semi-automated analyzers are now available in the market. The market report from Persistence Market Research predicts the hematology analyzer and reagent markets to expand at an impressive CAGR by the year 2021.
Key factors that fuel the growth of this market are:
- increasing adoption of automated hematology instruments
- increasing technological advancements
- integration of basic flow-cytometry techniques in modern hematology analyzers
- rising demand for high-throughput hematology analyzers
- development of high-sensitivity point-of-care (POC) hematology testing
However, the high cost of hematology analyzers, stringent and time-consuming regulatory policies for hematology instruments and intense competition among existing players are restraining the growth of the market.
End users of the hematology analyzers and reagents market include clinical testing laboratories, hospitals, and research institutions.
Owing to the regions’ high disposable income and increasing adoption of automated hematology instruments by diagnostics laboratories, North America dominates the market currently. However, due to factors such as developing healthcare infrastructure, increasing funding towards the development of hematology products, rising awareness about better healthcare and a large patient population base, Asia is expected to be the fastest growing market in the next five years.
Top manufacturers operating in this market are Sysmex Corporation, Abbott Laboratories, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Siemens Healthcare, HORIBA, Ltd. and NIHON KOHDEN CORPORATION.
Certain factors that provide opportunities for new players in the market include usage of microfluidics technology in hematology analyzers, introduction of digital imaging system in hematology laboratories, and increasing focus on emerging markets such as India and China. Also, increasing instances of partnership among manufacturers of hematology instruments and consumables are a recent market trend. However, safety and quality of hematology analyzers could be a challenge for the growth of this analyzer & reagent market.